Showing results (151-160 of 185) with videos related to

Sort By:
Pageof 19
Journal of the American College of Cardiology|November 21, 2017
1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus TicagrelorZuzana Motovska, Ota Hlinomaz, Petr Kala, et al.
European Journal of Internal Medicine|April 22, 2020
Heart rate as an independent predictor of long term mortality of acute heart failure patients in sinus rhythm according to their ejection fraction: data from the AHEAD registryJiri Jarkovsky, Jindrich Spinar, Benoit Tyl, et al.
International Journal of Cardiology|May 8, 2016
Natriuretic peptides in addition to Zwolle score to enhance safe and early discharge after acute myocardial infarction: A prospective observational cohort studyEva Ganovska, Mattia Arrigo, Katerina Helanova, et al.
Plos One|July 30, 2021
Prognostic value of high-sensitivity cardiac troponin I in heart failure patients with mid-range and reduced ejection fractionPetr Lokaj, Jindrich Spinar, Lenka Spinarova, et al.
International Journal of Cardiology|September 21, 2015
AHEAD score--Long-term risk classification in acute heart failureJindrich Spinar, Jiri Jarkovsky, Lenka Spinarova, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 8, 2013
Gain(1)(q21) is an unfavorable genetic prognostic factor for patients with relapsed multiple myeloma treated with thalidomide but not for those treated with bortezomibJan Smetana, Kristina Berankova, Romana Zaoralova, et al.
ESC Heart Failure|February 21, 2017
Worse prognosis of real-world patients with acute heart failure from the Czech AHEAD registry in comparison to patients from the RELAX-AHF trialJindrich Spinar, Jiri Jarkovsky, Lenka Spinarova, et al.
Hematological Oncology|January 13, 2025
MicroRNA Profiling of Bone Marrow Plasma Extracellular Vesicles in Multiple Myeloma, Extramedullary Disease, and Plasma Cell LeukemiaJana Gregorova, Monika Vlachova, Petra Vychytilova-Faltejskova, et al.
Leukemia Research|July 13, 2013
10 years of experience with thalidomide in multiple myeloma patients: report of the Czech Myeloma GroupJiri Minarik, Viera Sandecka, Vladimir Maisnar, et al.
American Heart Journal|December 17, 2016
Interventional left atrial appendage closure vs novel anticoagulation agents in patients with atrial fibrillation indicated for long-term anticoagulation (PRAGUE-17 study)Pavel Osmancik, Petr Tousek, Dalibor Herman, et al.
Pageof 19